Monitoring Response to Home Parenteral Nutrition in Adult Cancer Patients

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2020 Jun 27

PMID 32585965

Citations 3

Authors

Paolo Cotogni

Riccardo Caccialanza

Paolo Pedrazzoli

Federico Bozzetti

Antonella De Francesco

Affiliations

Soon will be listed here.

Abstract

Current guidelines recommend home parenteral nutrition (HPN) for cancer patients with chronic deficiencies of dietary intake or absorption when enteral nutrition is not adequate or feasible in suitable patients. HPN has been shown to slow down progressive weight loss and improve nutritional status, but limited information is available on the monitoring practice of cancer patients on HPN. Clinical management of these patients based only on nutritional status is incomplete. Moreover, some commonly used clinical parameters to monitor patients (weight loss, body weight, body mass index, and oral food intake) do not accurately reflect patient's body composition, while bioelectrical impedance analysis (BIA) is a validated tool to properly assess nutritional status on a regular basis. Therefore, patient's monitoring should rely on other affordable indicators such as Karnofsky Performance Status (KPS) and modified Glasgow Prognostic Score (mGPS) to also assess patient's functional status and prognosis. Finally, catheter-related complications and quality of life represent crucial issues to be monitored over time. The purpose of this narrative review is to describe the role and relevance of monitoring cancer patients on HPN, regardless of whether they are receiving anticancer treatments. These practical tips may be clinically useful to better guide healthcare providers in the nutritional care of these patients.

Citing Articles

Home Cancer Care Research: A Bibliometric and Visualization Analysis (1990-2021).

Fhoula B, Hadid M, Elomri A, Kerbache L, Hamad A, Al Thani M Int J Environ Res Public Health. 2022; 19(20).

PMID: 36293702 PMC: 9603182. DOI: 10.3390/ijerph192013116.

The Role of Nutritional Support for Cancer Patients in Palliative Care.

Cotogni P, Stragliotto S, Ossola M, Collo A, Riso S, The Intersociety Italian Working Group For Nutritional Support In Cancer Nutrients. 2021; 13(2).

PMID: 33498997 PMC: 7911232. DOI: 10.3390/nu13020306.

Nutrition in Cancer Therapy in the Elderly-An Epigenetic Connection?.

Blasiak J, Chojnacki J, Pawlowska E, Szczepanska J, Chojnacki C Nutrients. 2020; 12(11).

PMID: 33139626 PMC: 7692262. DOI: 10.3390/nu12113366.

References

Bozzetti F, Cozzaglio L, Biganzoli E, Chiavenna G, De Cicco M, Donati D . Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr. 2002; 21(4):281-8. DOI: 10.1054/clnu.2002.0560. View

Wengler A, Micklewright A, Hebuterne X, Bozzetti F, Pertkiewicz M, Moreno J . Monitoring of patients on home parenteral nutrition (HPN) in Europe: a questionnaire based study on monitoring practice in 42 centres. Clin Nutr. 2006; 25(4):693-700. DOI: 10.1016/j.clnu.2006.01.026. View

Raijmakers N, van Zuylen L, Costantini M, Caraceni A, Clark J, Lundquist G . Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects. Ann Oncol. 2011; 22(7):1478-1486. DOI: 10.1093/annonc/mdq620. View

Fearon K, Voss A, Hustead D . Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006; 83(6):1345-50. DOI: 10.1093/ajcn/83.6.1345. View

Bozzetti F . Nutritional support of the oncology patient. Crit Rev Oncol Hematol. 2013; 87(2):172-200. DOI: 10.1016/j.critrevonc.2013.03.006. View

Orrevall Y, Tishelman C, Permert J . Home parenteral nutrition: a qualitative interview study of the experiences of advanced cancer patients and their families. Clin Nutr. 2005; 24(6):961-70. DOI: 10.1016/j.clnu.2005.06.008. View

Siepler J . Principles and strategies for monitoring home parenteral nutrition. Nutr Clin Pract. 2007; 22(3):340-50. DOI: 10.1177/0115426507022003340. View

Ottery F . Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition. 1996; 12(1 Suppl):S15-9. DOI: 10.1016/0899-9007(96)90011-8. View

Cotogni P, Barbero C, Garrino C, Degiorgis C, Mussa B, De Francesco A . Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. Support Care Cancer. 2014; 23(2):403-9. PMC: 4289011. DOI: 10.1007/s00520-014-2387-9. View

10.

Reid J, McKenna H, Fitzsimons D, McCance T . Fighting over food: patient and family understanding of cancer cachexia. Oncol Nurs Forum. 2009; 36(4):439-45. DOI: 10.1188/09.ONF.439-445. View

11.

Cotogni P, Pittiruti M, Barbero C, Monge T, Palmo A, Boggio Bertinet D . Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. JPEN J Parenter Enteral Nutr. 2012; 37(3):375-83. DOI: 10.1177/0148607112460552. View

12.

Grundmann O, Yoon S, Williams J . The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients--a comprehensive review. Eur J Clin Nutr. 2015; 69(12):1290-7. DOI: 10.1038/ejcn.2015.126. View

13.

Cotogni P, Monge T, Fadda M, De Francesco A . Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition. BMC Cancer. 2018; 18(1):990. PMC: 6192128. DOI: 10.1186/s12885-018-4904-6. View

14.

Li R, Wu J, Ma M, Pei J, Song Y, Zhang X . Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions. Med Oncol. 2010; 28(3):689-96. DOI: 10.1007/s12032-010-9534-z. View

15.

Halpern-Silveira D, Susin L, Borges L, Paiva S, Assuncao M, Gonzalez M . Body weight and fat-free mass changes in a cohort of patients receiving chemotherapy. Support Care Cancer. 2009; 18(5):617-25. DOI: 10.1007/s00520-009-0703-6. View

16.

Proctor M, Morrison D, Talwar D, Balmer S, OReilly D, Foulis A . An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011; 104(4):726-34. PMC: 3049591. DOI: 10.1038/sj.bjc.6606087. View

17.

De Waele E, Demol J, Caccialanza R, Cotogni P, Spapen H, Malbrain M . Unidentified cachexia patients in the oncologic setting: Cachexia UFOs do exist. Nutrition. 2019; 63-64:200-204. DOI: 10.1016/j.nut.2019.02.015. View

18.

Russell M, Wischmeyer P . Supplemental Parenteral Nutrition: Review of the Literature and Current Nutrition Guidelines. Nutr Clin Pract. 2018; 33(3):359-369. DOI: 10.1002/ncp.10096. View

19.

Bozzetti F, Santarpia L, Pironi L, Thul P, Klek S, Gavazzi C . The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients. Ann Oncol. 2014; 25(2):487-93. DOI: 10.1093/annonc/mdt549. View

20.

Crawford G, Robinson J, Hunt R, Piller N, Esterman A . Estimating survival in patients with cancer receiving palliative care: is analysis of body composition using bioimpedance helpful?. J Palliat Med. 2009; 12(11):1009-14. DOI: 10.1089/jpm.2009.0093. View